Intron Biotechnology, Inc.

Hee Jeong Shin

SAng Hyeon Kang

Seong Jun Yoon

Soo Youn Jun

Jee Soo Son

Hyoun Rok Paik

Byung Wook Kim

Dong Min Kang

The present invention relates to Siphoviridae bacteriophage Clo-PEP-2 (accession number KCTC 13185BP), separated from nature, which is capable of killingand has a genome expressed by sequence number 1 and a method for preventing or treating diseases, induced by, by means of a composition comprising the Siphoviridae bacteriophage Clo-PEP-2 as an active ingredient.

bacteriophage Clo-PEP-2 and use for inhibitingproliferation of same

The present invention relates to Podoviridae bacteriophage Pse-AEP-4 (accession number: KCTC 13166BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-4 having the capability to specifically killand having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced byby using a composition containing the Podoviridae bacteriophage Pse-AEP-4 as an active ingredient.

bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of

The present invention relates tobacteriophage Pse-AEP-3 (accession number: KCTC 13165BP) isolated from nature, thebacteriophage Pse-AEP-3 having the capability to specifically killand having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced byby using a composition containing thebacteriophage Pse-AEP-3 as an active ingredient.

bacteriophage Pse-AEP-3 and use thereof for inhibiting proliferation of

The present invention relates to a Myoviridae bacteriophage Esc-CHP-1 that is isolated from the nature and can kill specifically enterohemorrhagicstrains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12660BP), and a method for preventing and treating the infections of enterohemorrhagicusing the composition comprising said bacteriophage as an active ingredient.

[object Object]

The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenicstrains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenicusing the composition comprising said bacteriophage as an active ingredient.

The present invention relates to a Myoviridae bacteriophage Esc-COP-4 that is isolated from the nature and can kill specifically enteroinvasivestrains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12663BP), and a method for preventing and treating the infections of enteroinvasiveusing the composition comprising said bacteriophage as an active ingredient.

The present invention relates to a Siphoviridae bacteriophage Lac-PLP-1 that is isolated from the nature and can killcells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12665BP), and a method for preventing and treating the contaminations ofby using the composition comprising the bacteriophage as an active ingredient.

Growing community of inventors

Gyeonggi-do, South Korea

Hee Jeong Shin